Investigation of a Therapeutic Vaccine (ACIT-1) in Cancer

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

April 25, 2017

Primary Completion Date

May 31, 2025

Study Completion Date

February 28, 2026

Conditions
CancerNeoplasms
Interventions
BIOLOGICAL

ACIT-1

Cell suspension

Trial Locations (2)

L7 8XP

Royal Liverpool University Hospital, Liverpool

CH63 4JY

The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Liverpool University Hospitals NHS Foundation Trust

OTHER_GOV

collaborator

The Clatterbridge Cancer Centre NHS Foundation Trust

OTHER

collaborator

University of Liverpool

OTHER

collaborator

Cancer Research UK

OTHER

collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

collaborator

Cancer Vaccines Charitable Trust

UNKNOWN

lead

Cancer Vaccines Limited

INDUSTRY